SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001628280-17-006866
Filing Date
2017-06-30
Accepted
2017-06-30 16:03:43
Documents
4
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a0331201710-ka.htm 10-K/A 50376
2 EXHIBIT 10.3 exhibit103.htm EX-10.3 74073
3 EXHIBIT 31.3 exhibit313.htm EX-31.3 7346
4 EXHIBIT 31.4 exhibit314.htm EX-31.4 7609
  Complete submission text file 0001628280-17-006866.txt   140527
Mailing Address 420 LEXINGTON AVENUE SUITE 2525 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2525 NEW YORK NY 10170 646-396-4087
Rasna Therapeutics Inc. (Filer) CIK: 0001582249 (see all company filings)

IRS No.: 392080103 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K/A | Act: 34 | File No.: 333-191083 | Film No.: 17942086
SIC: 2834 Pharmaceutical Preparations